Hamilton, United Kingdom

Jurgen Schulz

This inventor holds 1 USPTO granted patent. Top assignee: Msd Oss B.v.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jurgen Schulz. Retrieved from https://idiyas.com/inventor/jurgen-schulz-2lm31jkd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jurgen Schulz: Innovator in Fertility Control

Introduction

Jurgen Schulz is a notable inventor based in Hamilton, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the area of fertility control. His innovative work has led to the development of unique compounds that have potential applications in medical treatments.

Latest Patents

Jurgen Schulz holds a patent for tetrahydroquinoline derivatives. The present invention relates to these derivatives, which have a general formula I. Additionally, the invention encompasses pharmaceutical compositions that include these derivatives and their use in controlling fertility. This patent highlights his commitment to advancing medical science and improving healthcare options.

Career Highlights

Jurgen Schulz is associated with MSD Oss B.V., a company known for its focus on innovative healthcare solutions. His work at this organization has allowed him to contribute to important research and development projects that aim to enhance the quality of life for individuals seeking fertility control options.

Collaborations

Some of Jurgen Schulz's coworkers include Nicole Corine Renee Van Straten and Rudolf Gijsbertus Van Someren. Their collaboration in research and development has likely fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Jurgen Schulz's contributions to the field of pharmaceuticals, particularly through his patent on tetrahydroquinoline derivatives, demonstrate his dedication to innovation in fertility control. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…